콘드로이틴황산 시장 : 유래별, 형태별, 용도별, 예측(2023-2032년)

Chondroitin sulfate market size is anticipated to record 3.4% CAGR from 2023 to 2032 due to the growing aging population that has led to an increase in age-related joint issues, such as osteoarthritis. The product acts as a natural and effective solution. Based on data from the Behavioral Risk Factor Surveillance System (BRFSS), nearly 25.9% of American adults aging 18 years or older are expected to be diagnosed of arthritis by 2040.

The consumer shift towards preventive healthcare, as well as the increasing adoption of dietary supplements for overall well-being are boosting product demand. Furthermore, extensive R&D efforts have resulted in the development of innovative formulations and enhanced bioavailability of chondroitin sulfate products, catering to the diverse needs of consumers.

Chondroitin sulfate market is classified based on source, form, application, and region.

The marine source segment is predicted to witness substantial growth through 2032 due to the higher purity and bioavailability of chondroitin sulfate. Consumers are increasingly preferring marine-based product over alternatives, given its superior quality. Investments in R&D are focusing on sustainable sourcing practices, ensuring the long-term source availability. As marine sourced chondroitin sulfate gains traction, it is expected to maintain a prominent position in the market.

The capsules/tablets segment is expected to generate high revenues by 2032 as they are convenient and easy-to-consume forms. They have gained favor among consumers looking for hassle-free supplementation. Capsules or tablets offer precise dosage control, making it a preferred choice for individuals managing joint health. As product development advances, manufacturers are introducing innovative delivery systems and combination products that enhance the effectiveness of chondroitin sulfate capsules and tablets.

North America chondroitin sulfate industry size will grow significantly through 2032 primarily driven by the increasing prevalence of joint-related disorders. The United States, in particular, has witnessed a surge in consumer awareness about joint health and the benefits of chondroitin sulfate supplementation. Furthermore, the well-established dietary supplement industry and stringent quality standards have contributed to the growth of the market. The producers in this region are increasingly focusing on product innovation and expanding their distribution networks to cater to the burgeoning demand for chondroitin sulfate.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definition
• 1.3 Base estimates & calculations
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data Sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Chondroitin sulfate industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Source trends
• 2.4 Form trends
• 2.5 Application trends
• 2.6 Regional trends

Chapter 3 Chondroitin Sulfate Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls & challenges
• 3.3 Growth potential analysis
  • 3.3.1 By source
  • 3.3.2 By form
  • 3.3.3 By application
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Pricing analysis, 2022
• 3.7 Technology landscape
  • 3.7.1 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Impact of Russia Ukraine war

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Global company market share analysis, 2022
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Chondroitin Sulfate Market Size and Forecast, By Source 2018 - 2032

• 5.1 Bovine
• 5.2 Porcine
• 5.3 Avian
• 5.4 Marine
• 5.5 Others

Chapter 6 Chondroitin Sulfate Market Size and Forecast, By Form 2018 - 2032

• 6.1 Powder
• 6.2 Capsules/Tablets
• 6.3 Liquid

Chapter 7 Chondroitin Sulfate Market Size and Forecast, By Application 2018 - 2032

• 7.1 Dietary Supplements
• 7.2 Pharmaceuticals (Joint Health Products)
• 7.3 Cosmetics and Personal Care
• 7.4 Food and Beverages
• 7.5 Others

Chapter 8 Chondroitin Sulfate Market Size and Forecast, By Region 2018 - 2032

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Indonesia
  • 8.4.7 Malaysia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Egypt

Chapter 9 Company Profiles

• 9.1 TSI Group Ltd.
• 9.2 Synutra Ingredients (Shandong) Co., Ltd.
• 9.3 Yantai Dongcheng Pharmaceutical Group Co., Ltd.
• 9.4 Jiaxing Hengjie Biopharmaceutical Co., Ltd.
• 9.5 Qufu Liyang Biochem Industrial Co., Ltd.
• 9.6 Pacific Rainbow International, Inc.
• 9.7 Shandong Runxin Biotechnology Co., Ltd.
• 9.8 ZPD A/S
• 9.9 Guangdong Hybribio Biotech Co., Ltd.
• 9.10 Wanbury Limited
• 9.11 Sierra Ingredients Pty Ltd.
• 9.12 BGM Pharmaceuticals Co., Ltd.
• 9.13 YBCC (Qingdao) Co., Ltd.
• 9.14 Anhui Jintung Fine Chemical Corporation Ltd.
• 9.15 Zhejiang Aoxing Biotechnology Co., Ltd.